It is a privilege to welcome these esteemed Members of the European Parliament to the 3rd ESIP Annual Forum in Brussels on 15 October
'The welfare states & Europe’s competitiveness: Friends or foes?'
#ESIPForum#SocialSecurity#SocialEurope
https://t.co/UobsDPUBGB
Mobility of workers & workforce shortages: How do we solve this conundrum? What are the implications for #socialprotection?
ESIP experts will offer their insights during the 3rd ESIP Annual Forum in Brussels on 15 October!
#ESIPForum#MeetTheSpeakers
https://t.co/kGQ0WEAQR8
A strong welfare state for a socially robust single market: The role of social security
3rd ESIP Annual Forum (Brussels, 15 October 2024)
All-day event, 4 sessions, 20 speakers, 3 MEPs
Register today!
https://t.co/mTopQLereV
#SocialEurope#SocialSecurity#SocialProtection
Register today and join us in Brussels on 15 October for the 3rd ESIP Annual Forum
Panel III of the Forum composed of ESIP experts will discuss the high prices of #medicines & much more!
https://t.co/mTopQLereV
#SocialEurope#accesstomedicines#socialprotection
ESIP's Members, public payers' demands for #EUPharmaRevision:
- Baseline for regulatory data protection (RDP) down to 6 years
- Cumulative duration of regulatory protection should NOT exceed existing threshold
- TEVs = no go
Here are our recommendations: https://t.co/3uzqjTIxHc
Director @YNatsis mentions the value of a regulatory framework that promotes #competition
“The #EUPharmaRevision has the potential to rebalance the system and ensure that #biosimilar and #generic products enter the market earlier”
Find out how🔎 https://t.co/bvLJbaTaLl
Today we join the 7th #biosimilars stakeholder event hosted by @EU_Health
Losses of #exclusivities are expected in the near future: how to address lack of #biosimilar competition, reboost the biosimilar pipeline, promote biosimilar #uptake and #access?
.@YNatsis: we need to bring closer regulators, #HTA and #payers to align our #StrongEvidence requirements and our understanding of neglected medical and societal
#needs
More in our proposals on the #EUPharmaRevision ➡️ https://t.co/bvLJbaTaLl
Director @YNatsis on stage today at KCE 20th Anniversary symposium: how is the #pharma ecosystem changing? What is the legacy of the #pandemic and global #permacrises? What role for the #EUPharmaRevision: a revolution for #StrongEvidence based decisions or much of the same?
Discussing #StrongEvidence vs uncertainties, Denis Lacombe, @EORTC Director General calls to always push for the most robust methodology to generate evidence.
“We often hear that clinical studies cannot be randomised, but they could”
We agree✅
Attending today the 2nd HTA Stakeholder Network meeting.
Increased uncertainty at the time of approval creates problems down the road. We need to tackle the evidence gaps early on.
Here is how: https://t.co/bvLJbaTaLl
#StrongEvidence#SustainableHealthcare
.#EUSocialForum 2023 day 2, focus on #algorithmic management & the #labourmarket. How compatible is it with critical thinking? Can we ensure that the creative thinking of the workers does not get lost? More questions, than answers at this stage.
#SocialEurope#SocialProtection
Welcome to the #EUSocialForum 2023!
2 800 people registered to discuss #AI and the world of work 👏
Speakers:
🎙️ Nobel Prize winner Chris Pissarides
🎙️ Commissioner @NicolasSchmitEU
🎙️"Greta Thunberg of AI" @sneharevanur
& more
🔴 Register & follow live from 13.00 CET ⇩
“It affects white collar jobs as opposed to the past where many changes were limited to blue collar jobs” notes the head of the German Federal Employment Agency (BA) #EUSocialForum
Attending #EUSocialForum, the annual flagship event of @EU_Social in Brussels today. Emphasis on #AI & the #worldofwork. ESIP Member, the German Federal Employment Agency now on plenary: “We have a decade of automation ahead of us-important to communicate why we do it”